Keith Manchester

Director/Board Member at ROIVANT SCIENCES LTD.

Net worth: 62 M $ as of 30/06/2026

57 year

46 connections

Health Technology

Finance

Consumer Services

Profile

Keith S.
Manchester currently works at Roivant Sciences Ltd., as Independent Director from 2014, Roivant Sciences, Inc., as Director from 2014, Kriya Therapeutics, Inc., as Director, and QVT Financial LP, as Partner & Portfolio Manager from 2005.
Dr. Manchester also formerly worked at Resolvyx Pharmaceuticals, Inc., as Director, Arbutus Biopharma, Inc., as Director from 2014 to 2015, Myovant Sciences Ltd., as Director from 2016 to 2018, Montes Archimedes Acquisition Corp., as Independent Director, Arbutus Biopharma Corp., as Independent Director from 2015 to 2025, Applied Molecular Evolution, Inc., as Vice President-Business Development from 2002 to 2004, VCP I Inc, as Associate from 1997 to 1998, MediGene AG, as Independent Member-Supervisory Board, and Life Sciences Qvt Financial LP, as Partner & Head.
Dr. Manchester received his doctorate degree from Harvard Medical School and undergraduate degree from Harvard College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ROIVANT SCIENCES LTD. 0.24%	30/06/2026	1,748,403 ( 0.24% )	62 M $	30/06/2026

Keith Manchester active positions

Companies	Position	Start
ROIVANT SCIENCES LTD.	Director/Board Member	01/01/2014
QVT Financial LP QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology.	Portfolio Manager-Equities	01/01/2005
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Director/Board Member	01/01/2014
Kriya Therapeutics, Inc. Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases	Director/Board Member	-

All active positions of Keith Manchester

Former positions of Keith Manchester

Companies	Position	End
ARBUTUS BIOPHARMA CORPORATION	Director/Board Member	24/02/2025
MYOVANT SCIENCES LTD.	Director/Board Member	20/09/2018
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions	Director/Board Member	01/03/2015
VCP I Inc VCP I Inc Investment ManagersFinance VCP invests in middle market companies located in the United States. The firm focuses on sectors such as consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements and acquires both control and minority investments. It also makes follow-on investments.	Corporate Officer/Principal	31/12/1998
ROIVANT SCIENCES LTD.	Director/Board Member	-

See the detail of Keith Manchester's experience

Training of Keith Manchester

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Manchester's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	15
Applied Molecular Evolution, Inc. Applied Molecular Evolution, Inc. BiotechnologyHealth Technology Develops and manufactures proteins & genes for commercial purposes	Health Technology
QVT Financial LP QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology.	Finance
Resolvyx Pharmaceuticals, Inc. Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for inflammatory diseases	Health Technology
Arbutus Biopharma Corp. Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases	Health Technology
Arbutus Biopharma, Inc. Arbutus Biopharma, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical solutions	Health Technology
Roivant Sciences Ltd. Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases	Health Technology
VCP I Inc VCP I Inc Investment ManagersFinance VCP invests in middle market companies located in the United States. The firm focuses on sectors such as consumer, healthcare and business & technology services. It provides financing for buyout, MBO, carve-outs and growth capital requirements and acquires both control and minority investments. It also makes follow-on investments.	Finance
MediGene AG MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Myovant Sciences Ltd. Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions	Health Technology
Roivant Sciences, Inc. Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs	Health Technology
Life Sciences Qvt Financial LP
Kriya Therapeutics, Inc. Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases	Health Technology
Montes Archimedes Acquisition Corp. Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance